[go: up one dir, main page]

GB527803A - Improvements in and relating to the manufacture of bacterial antigenic and/or immunogenic preparations - Google Patents

Improvements in and relating to the manufacture of bacterial antigenic and/or immunogenic preparations

Info

Publication number
GB527803A
GB527803A GB11939/39A GB1193939A GB527803A GB 527803 A GB527803 A GB 527803A GB 11939/39 A GB11939/39 A GB 11939/39A GB 1193939 A GB1193939 A GB 1193939A GB 527803 A GB527803 A GB 527803A
Authority
GB
United Kingdom
Prior art keywords
salts
antigenic
preparations
immunogenic
organisms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB11939/39A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Laboratories Ltd
Original Assignee
Glaxo Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Laboratories Ltd filed Critical Glaxo Laboratories Ltd
Priority to GB11939/39A priority Critical patent/GB527803A/en
Publication of GB527803A publication Critical patent/GB527803A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

527,803. Antigenic and like preparations. HAWORTH, W. N., STACEY, M., HEMS, B. A., ROBINSON, F. A., and GLAXO LABORATORIES, Ltd. April 20, 1939; No. 11939. [Class 81 (i)] Antigenic and immunogenic preparations are obtained from bacterial cultures by dissolving therefrom a polysaccharide complex by treatment of the cells with solutions of salts of primary, secondary and tertiary amines, amides, and their derivatives and hydrazines, e.g. the salts of guanidide, mono-, di- and tri-ethanolamine, pyridine, quinoline, piperidine and morpholine. Such a solution, prepared for example by trituration of cells of B. typhosum with guanidine acetate is precipitated by addition of alcohol, the immunogenic polysaccharide complex is collected and is nearly free from extraneous protein. Other organisms which may be extracted are pneumococci, gram-negative haemophilic organisms, bacteria of the coli-typhoid-dysentera-salmonella group and gram-negative cocci. The use of salts of urea is disclaimed.
GB11939/39A 1939-04-20 1939-04-20 Improvements in and relating to the manufacture of bacterial antigenic and/or immunogenic preparations Expired GB527803A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB11939/39A GB527803A (en) 1939-04-20 1939-04-20 Improvements in and relating to the manufacture of bacterial antigenic and/or immunogenic preparations

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB11939/39A GB527803A (en) 1939-04-20 1939-04-20 Improvements in and relating to the manufacture of bacterial antigenic and/or immunogenic preparations

Publications (1)

Publication Number Publication Date
GB527803A true GB527803A (en) 1940-10-16

Family

ID=9995420

Family Applications (1)

Application Number Title Priority Date Filing Date
GB11939/39A Expired GB527803A (en) 1939-04-20 1939-04-20 Improvements in and relating to the manufacture of bacterial antigenic and/or immunogenic preparations

Country Status (1)

Country Link
GB (1) GB527803A (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2798836A (en) * 1954-01-18 1957-07-09 American Cyanamid Co Inhalable live virus veterinary vaccine
US2798835A (en) * 1954-01-18 1957-07-09 American Cyanamid Co Newcastle disease and infectious bronchitis vaccines and production thereof
DE1041648B (en) * 1956-02-06 1958-10-23 Ici Ltd Process for the production of pharmaceutical preparations containing antigens
US2965543A (en) * 1953-07-03 1960-12-20 Merck & Co Inc Alcohol detoxification of pertussis vaccines
US3148121A (en) * 1960-01-27 1964-09-08 Miles Lab Water-insoluble whole inhalant complex and method of making same
US3148122A (en) * 1960-01-27 1964-09-08 Miles Lab Water-insoluble whole pollen complex and method of making same
US3450815A (en) * 1964-04-24 1969-06-17 Princeton Lab Inc Method of stimulating a host defense mechanism with an actinovaccine
FR2366359A1 (en) * 1976-10-02 1978-04-28 Behringwerke Ag PROCESS FOR THE EXTRACTION OF MICRO-ORGANISMS AND PRODUCTS OBTAINED USABLE AS DIAGNOSTIC AGENTS

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2965543A (en) * 1953-07-03 1960-12-20 Merck & Co Inc Alcohol detoxification of pertussis vaccines
US2798836A (en) * 1954-01-18 1957-07-09 American Cyanamid Co Inhalable live virus veterinary vaccine
US2798835A (en) * 1954-01-18 1957-07-09 American Cyanamid Co Newcastle disease and infectious bronchitis vaccines and production thereof
DE1041648B (en) * 1956-02-06 1958-10-23 Ici Ltd Process for the production of pharmaceutical preparations containing antigens
US3148121A (en) * 1960-01-27 1964-09-08 Miles Lab Water-insoluble whole inhalant complex and method of making same
US3148122A (en) * 1960-01-27 1964-09-08 Miles Lab Water-insoluble whole pollen complex and method of making same
US3450815A (en) * 1964-04-24 1969-06-17 Princeton Lab Inc Method of stimulating a host defense mechanism with an actinovaccine
FR2366359A1 (en) * 1976-10-02 1978-04-28 Behringwerke Ag PROCESS FOR THE EXTRACTION OF MICRO-ORGANISMS AND PRODUCTS OBTAINED USABLE AS DIAGNOSTIC AGENTS

Similar Documents

Publication Publication Date Title
GB527803A (en) Improvements in and relating to the manufacture of bacterial antigenic and/or immunogenic preparations
Shaffer et al. Studies on measles: II. Experimental disease in man and monkey
Rebers et al. Fowl cholera: induction of cross-protection in turkeys with bacterins prepared from host-passaged Pasteurella multocida
Swift et al. Pathogenic pleuropneumonia-like microorganisms from acute rheumatic exudates and tissues
Guerrant et al. Tickborne oculoglandular tularemia: case report and review of seasonal and vectorial associations in 106 cases
Johnstone et al. Role of infection in cot deaths
Weibel et al. Respiratory Virus Vaccines: VII. Field Evaluation of Respiratory Syncytial, Parainfluenza 1, 2, 3, and Mycoplasma Pneumoniae Vaccines, 1965 to 1966
Spring et al. Studies on the action of sulfapyridine on pneumococci
Chain et al. The discovery of the chemotherapeutic properties of penicillin
Forrer et al. Distribution of hemolytic streptococci in respiratory specimens
Smith Chlorophyll as the prosthetic group of a protein in the green leaf
Dochez et al. Filtrable viruses in infection of the upper respiratory tract
Asenjo et al. A New Protease from Bromella pinguin L.
Carr Prolonged antibody production following recovery of fowls from Rous No. 1 sarcoma
Benson The role of bacteria in allergy, with special reference to asthma
Hennessy An attempt to demonstrate a viral etiology for chronic bronchitis
Briggs et al. Studies in cryptococcal fever. I. Responses to intact organisms and to a soluble agent derived from cryptococci
Hepper Artificial infection of various molluscs with Mytilicola intestinalis, Steuer
HATTA et al. STUDIES ON “MACRAMIN”, A NEW HIGH-MOLECULAR ANTIBACTERIAL SUBSTANCE DERIVED FROM CHITIN
Morris et al. An outbreak of typhoid fever due to the small colony variety of Eberthella typhosa
Stout Saprophilus muscorum Kahl, a tetrahymenal ciliate
Labzoffsky et al. Isolation of a haemadsorption virus from the recent outbreak of respiratory illness in Ontario
Stones Isolation of ECHO virus type 9 during an outbreak of meningo-encephalitis
US1507942A (en) Stable vaccine
Muirhead-Thomson The Identity of ‘Eye-Flies’ in Assam